Study finds repurposed drug inhibits enzyme related to COVID-19
Scientists identify sensor underlying mechanical itch stimulus
22 June 2022Researchers find medical industry funded studies more likely to find new treatments cost effective
22 June 2022Study finds repurposed drug inhibits enzyme related to COVID-19
With the end of the pandemic seemingly nowhere in sight, scientists are still very focused on finding new or alternative drugs to treat and stop the spread of COVID-19. In a first-of-its-kind study, researchers at the University of New Hampshire have found that using an already existing drug compound in a new way, known as drug repurposing, could be successful in blocking the activity of a key enzyme of the coronavirus, or SARS-CoV-2, which causes COVID-19.
